[go: up one dir, main page]

WO2002036609A3 - Haplotypes du gene chrm4 - Google Patents

Haplotypes du gene chrm4 Download PDF

Info

Publication number
WO2002036609A3
WO2002036609A3 PCT/US2001/045709 US0145709W WO0236609A3 WO 2002036609 A3 WO2002036609 A3 WO 2002036609A3 US 0145709 W US0145709 W US 0145709W WO 0236609 A3 WO0236609 A3 WO 0236609A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
chrm4
gene
disclosed
chrm4 gene
Prior art date
Application number
PCT/US2001/045709
Other languages
English (en)
Other versions
WO2002036609A2 (fr
Inventor
R Rex Denton
Amy Duda
Christopher Raleigh Gilson
Amir Kazemi
Krishnan Nandabalan
Charles Tirrell
Original Assignee
Genaissance Pharmaceuticals
R Rex Denton
Amy Duda
Christopher Raleigh Gilson
Amir Kazemi
Krishnan Nandabalan
Peterson Nathan
Rounds Eileen
Charles Tirrell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, R Rex Denton, Amy Duda, Christopher Raleigh Gilson, Amir Kazemi, Krishnan Nandabalan, Peterson Nathan, Rounds Eileen, Charles Tirrell filed Critical Genaissance Pharmaceuticals
Priority to AU2002228727A priority Critical patent/AU2002228727A1/en
Publication of WO2002036609A2 publication Critical patent/WO2002036609A2/fr
Publication of WO2002036609A3 publication Critical patent/WO2002036609A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux variants du gène muscarinique 4 à récepteur cholinergique (CHRM4). Divers génotypes, haplotypes, et paires d'haplotypes existant dans la population des Etats-Unis sont décrits pour le gène CHRM4. L'invention concerne également des compositions et des procédés visant à haplotyper et/ou génotyper le gène CHRM4 chez un individu, ainsi que des polynucléotides définis par les haplotypes.
PCT/US2001/045709 2000-10-31 2001-10-31 Haplotypes du gene chrm4 WO2002036609A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002228727A AU2002228727A1 (en) 2000-10-31 2001-10-31 Haplotypes of the chrm4 gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24462700P 2000-10-31 2000-10-31

Publications (2)

Publication Number Publication Date
WO2002036609A2 WO2002036609A2 (fr) 2002-05-10
WO2002036609A3 true WO2002036609A3 (fr) 2002-09-06

Family

ID=22923502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/045709 WO2002036609A2 (fr) 2000-10-31 2001-10-31 Haplotypes du gene chrm4

Country Status (2)

Country Link
AU (1) AU2002228727A1 (fr)
WO (1) WO2002036609A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004071392A2 (fr) * 2003-02-11 2004-08-26 Bayer Healthcare Ag Agents de diagnostic et de traitement destines aux maladies associees au recepteur acetylcholine, muscarinique 4(m4)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] October 1994 (1994-10-01), BONNER ET AL.: "Human m4 muscarinic acetylcholine receptor gene", XP002950833, Database accession no. (M16405) *
DATABASE SNP [online] NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); April 2001 (2001-04-01), XP002950629, retrieved from SS72979107 accession no. NCBI Database accession no. (RS2067482) *
DATABASE SNP [online] NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); June 2001 (2001-06-01), XP002950630, retrieved from SS3176155 accession no. NCBI Database accession no. (RS2229163) *
KOPPEN ET AL.: "Isolation, sequence and functional expression of the mouse m4 muscarinic acetylcholine receptor gene", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1173, 1993, pages 342 - 344, XP002950828 *
SCIENCE, vol. 237, no. 4814, 1987, pages 527 - 532 *

Also Published As

Publication number Publication date
WO2002036609A2 (fr) 2002-05-10
AU2002228727A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2002036609A3 (fr) Haplotypes du gene chrm4
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2001087908A3 (fr) Haplotypes du gene ccr3
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2001096350A3 (fr) Haplotypes du gene grm3
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002094850A3 (fr) Haplotypes du gene gnrh2
WO2001090115A3 (fr) Haplotypes du gene cdk4
WO2001092278A3 (fr) Haplotypes du gene rlbp1

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP